Cargando…
Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence
Atypical haemolytic uraemic syndrome (aHUS) is a rare disease characterized by thrombocytopenia, microangiopathic haemolytic anaemia and renal impairment. Mutations in genes encoding inhibitors of the alternative pathway of the complement system are involved in ∼50% of the cases. Thrombomodulin (THB...
Autores principales: | Caroti, Leonardo, Di Maria, Lorenzo, Carta, Paolo, Moscarelli, Luciano, Cirami, Calogero, Minetti, Enrico Eugenio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440472/ https://www.ncbi.nlm.nih.gov/pubmed/26034596 http://dx.doi.org/10.1093/ckj/sfv025 |
Ejemplares similares
-
New combined CFH/MCP mutations and a rare clinical course in atypical haemolytic uraemic syndrome
por: Lopes, Daniela, et al.
Publicado: (2015) -
Eculizumab in secondary atypical haemolytic uraemic syndrome
por: Cavero, Teresa, et al.
Publicado: (2017) -
AZD-1222: Atypical haemolytic uraemic syndrome recurrence: case report
Publicado: (2022) -
Early treatment with eculizumab in atypical haemolytic uraemic syndrome
por: Garjau, Maria, et al.
Publicado: (2012) -
Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
por: Syed, Yahiya Y.
Publicado: (2021)